259 related articles for article (PubMed ID: 379629)
1. Mutagenicity of phenanthrene and phenanthrene K-region derivatives.
Bücker M; Glatt HR; Platt KL; Avnir D; Ittah Y; Blum J; Oesch F
Mutat Res; 1979 Apr; 66(4):337-48. PubMed ID: 379629
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity of N-substituted phenanthrene 9,10-imines in Salmonella typhimurium and Chinese hamster V79 cells.
Glatt H; Shtelzer S; Sheradsky T; Blum J; Oesch F
Environ Mutagen; 1986; 8(6):829-37. PubMed ID: 3536471
[TBL] [Abstract][Full Text] [Related]
3. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways.
Oesch F; Bücker M; Glatt HR
Mutat Res; 1981 Mar; 81(1):1-10. PubMed ID: 7019683
[TBL] [Abstract][Full Text] [Related]
4. Arene imines, a new class of exceptionally potent mutagens in bacterial and mammalian cells.
Glatt H; Ludewig G; Platt KL; Waechter F; Yona I; Ben-Shoshan S; Jerushalmy P; Blum J; Oesch F
Cancer Res; 1985 Jun; 45(6):2600-7. PubMed ID: 3921247
[TBL] [Abstract][Full Text] [Related]
5. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships in the mutagenicity of N-substituted derivatives of phenanthrene-9,10-imine.
Stark AA; Zeiger E; Shtelzer S; Sheradsky T; Lifshitz Y; Blum J
Mutagenesis; 1986 Jan; 1(1):35-9. PubMed ID: 3325734
[TBL] [Abstract][Full Text] [Related]
7. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
9. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants.
Swanson AB; Chambliss DD; Blomquist JC; Miller EC; Miller JA
Mutat Res; 1979 Apr; 60(2):143-53. PubMed ID: 379623
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity of K-region epoxides of polycyclic aromatic compounds: structure-activity relationship.
Miyata N; Shudo K; Kitahara Y; Huang GF; Okamoto T
Mutat Res; 1976 Nov; 37(2-3):187-91. PubMed ID: 794704
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic and cytotoxic activity of benzol[a]pyrene 4,5-, 7,8-, and 9,10-oxides and the six corresponding phenols.
Wood AW; Goode RL; Chang RL; Levin W; Conney AH; Yagi H; Dansette PM; Jerina DM
Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3176-80. PubMed ID: 1103140
[TBL] [Abstract][Full Text] [Related]
12. cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimurium.
Glatt HR; Robertson LW; Arand M; Rauch P; Schramm H; Setiabudi F; Pöchlauer P; Müller EP; Oesch F
Arch Toxicol; 1986 Dec; 59(4):242-8. PubMed ID: 3548649
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of substituted carbazoles in Salmonella typhimurium.
LaVoie EJ; Briggs G; Bedenko V; Hoffmann D
Mutat Res; 1982 Apr; 101(2):141-50. PubMed ID: 7048081
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
Wislocki PG; Wood AW; Chang RL; Levin W; Yagi H; Hernandez O; Dansette PM; Herina DM; Conney AH
Cancer Res; 1976 Sep; 36(9 pt.1):3350-7. PubMed ID: 788898
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic activity of thiram in Ames tester strains of Salmonella typhimurium.
Zdzienicka M; Zieleńska M; Tudek B; Szymczyk T
Mutat Res; 1979 Sep; 68(1):9-13. PubMed ID: 386113
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives.
Pezzuto JM; Swanson SM; Mar W; Che CT; Cordell GA; Fong HH
Mutat Res; 1988 Dec; 206(4):447-54. PubMed ID: 3060719
[TBL] [Abstract][Full Text] [Related]
17. The mutagenicity of halogenated alkanols and their phosphoric acid esters for Salmonella typhimurium.
Nakamura A; Tateno N; Kojima S; Kaniwa MA; Kawamura T
Mutat Res; 1979 Apr; 66(4):373-80. PubMed ID: 379633
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay).
Suter W; Matter-Jaeger I
Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity testing of the antiparasitic drug entizol (polfa) in the detection system of Salmonella typhimurium mutants.
Dobiás L
Mutat Res; 1980 Feb; 77(2):117-26. PubMed ID: 6990236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
